Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

XtalPi Announces Partnership with Parthenon Therapeutics

Wednesday, September 06, 2023

XtalPi and Parthenon Therapeutics have announced a collaboration aimed at the discovery of innovative therapeutic antibodies for the treatment of solid tumours.

Under this agreement, XtalPi will grant Parthenon Therapeutics access to its cutting-edge XupremAb™ antibody discovery platform. This platform represents a comprehensive suite of solutions that seamlessly integrate artificial intelligence (AI) and wet lab techniques. The result is the rapid identification of therapeutic antibody candidates boasting exceptional efficacy and developability profiles.

Parthenon Therapeutics and XtalPi will use different methods within the XupremAb™ platform to better explore the immune system. This collaboration represents a promising step towards improving the lives of cancer patients through innovative and effective therapies.

This collaboration harnesses the power of a proprietary platform at the forefront of technological advancement. Its primary objective is to conduct an in-depth exploration of the immune repertoire, ultimately leading to the discovery of state-of-the-art antibody therapeutics. 

Combined with Parthenon's extensive expertise in biotherapeutic drug discovery, including invaluable insights into the intricacies of the tumour microenvironment and mechanisms responsible for immune exclusion, this partnership is poised to pave the way for transformative cancer therapies.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024